Ghost Tree Capital, LLC
- SEC CIK
- 0001595851
- Latest filing
- Nov 14, 2024
CLDX holding history
Celldex Therapeutics, Inc. in every 13F filed by Ghost Tree Capital, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
CLDX overviewAll 13F holders of CLDXFull Q3 2024 holdings
- Shares (Q2 2022)
- 0
- Sold out in Q2 2022
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 5
- Since Q1 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2022 | 0 | $0 | 0.0% | −300,000−100.0% | Sold out | Holders |
| Q1 2022 | 300,000 | $10.2M | 5.1% | −50,000−14.3% | Reduced | Holders |
| Q4 2021 | 350,000 | $13.5M | 5.2% | +95,000+37.3% | Added | Holders |
| Q3 2021 | 255,000 | $13.8M | 4.5% | −30,000−10.5% | Reduced | Holders |
| Q2 2021 | 285,000 | $9.53M | 3.0% | +35,000+14.0% | Added | Holders |
| Q1 2021 | 250,000 | $5.15M | 1.4% | – | – | Holders |
Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.